Sopharma AD
No trades
0.52 PLN
167.13 M PLN
4.66 B PLN
392.91 M
About Sopharma AD
Sector
Industry
CEO
Ognian Ivanov Donev
Website
Headquarters
Sofia
Founded
1933
IPO date
Jan 20, 1998
Identifiers
2
ISIN BG11SOSOBT18
Sopharma AD engages in the provision of pharmaceutical business. Its operations include production and marketing of medical products, medicinal substances as well as dosage forms. It also involved in research, engineering, and implementation activities in the field of phytochemistry, chemistry, and pharmacy. The firm offers dermatological products, gastroenterological, as well as psychoneurological, antiallergic and others. The company was founded in 1933 and is headquartered in Sofia, Bulgaria.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SPH is 8.30 PLN — it has decreased by −6.74% in the past 24 hours. Watch Sopharma AD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange Sopharma AD stocks are traded under the ticker SPH.
SPH stock has fallen by −33.86% compared to the previous week, the month change is a −33.86% fall, over the last year Sopharma AD has showed a 100.81% increase.
We've gathered analysts' opinions on Sopharma AD future price: according to them, SPH price has a max estimate of 7.71 PLN and a min estimate of 7.71 PLN. Watch SPH chart and read a more detailed Sopharma AD stock forecast: see what analysts think of Sopharma AD and suggest that you do with its stocks.
Today Sopharma AD has the market capitalization of 4.26 B, it has increased by 5.65% over the last week.
Yes, you can track Sopharma AD financials in yearly and quarterly reports right on TradingView.
SPH net income for the last quarter is 88.18 M PLN, while the quarter before that showed 65.35 M PLN of net income which accounts for 34.92% change. Track more Sopharma AD financial stats to get the full picture.
Sopharma AD dividend yield was 2.68% in 2024, and payout ratio reached 33.36%. The year before the numbers were 17.31% and 134.77% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sopharma AD EBITDA is 387.11 M PLN, and current EBITDA margin is 5.83%. See more stats in Sopharma AD financial statements.
Like other stocks, SPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sopharma AD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sopharma AD technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sopharma AD stock shows the buy signal. See more of Sopharma AD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.